Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: evidence from a genome-wide association meta-analysis followed by mendelian randomization - Zheng, Jie; Wheeler, Eleanor; Pietzner, Maik; Andlauer, Till F. M.; Yau, Michelle S.; Hartley, April E.; Brumpton, Ben Michael; Rasheed, Humaira; Kemp, John P.; Frysz, Monika; Robinson, Jamie; Reppe, Sjur; et al. (Arthritis & rheumatology, 2023)
Online veröffentlicht: 25. April 2023